Recently-listed lead drug developer, Phylogica has announced the appointment of Greg Pullen as a non-executive director.
Dr Pullen recently headed the licensing and company start-up group at Auckland UniServices Ltd, the commercialisation entity of the University of Auckland.
Before joining UniServices, he held senior executive positions in the Australian biotech and pharmaceutical sector.